Don't miss your chance - anyone interested in applying?
posted on
Jul 05, 2022 07:36AM
https://ca.indeed.com/Resverlogix-Corp-jobs?vjk=60f74d618d1e2ef9
Title: Director, Scientific Development
Job Description:
The Director of Scientific Development provides support to the Resverlogix team in meeting research and development objectives by contributing to the conduct and monitoring of scientific research studies both internally and externally. The Director is responsible for scientific, medical and regulatory writing, preparation of scientific manuscripts, presentations and clinical documents, and provides support in managing Resverlogix’ research and development program, reporting directly to the Senior Vice President of Research & Development.
Roles and Responsibilities:
Qualifications:
Location: Calgary, Alberta
Application deadline: July 30, 2022 - successful applicants will be contacted for interviews as they are identified.
Please send one page cover letter, stating short and long term career goals and resume with e-mail titled: Director, Scientific Development.
Resverlogix is an equal opportunity employer, we value diversity in our workforce and believe inclusive workplaces are stronger workplaces. We encourage all qualified candidates to apply.
About Resverlogix:
Resverlogix is a late-stage clinical biotechnology company, located in Calgary, Alberta, dedicated to improving the lives of patients with chronic illnesses. We are developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. Our flagship drug, apabetalone, is a first-in-class selective inhibitor of bromodomain and extra-terminal domain (BET) proteins, which aims to improve patients’ lives by restoring biological functions back to a healthier state. Due to the extensive role for BET proteins in the human body, apabetalone, can simultaneously target multiple disease-related biological processes while maintaining a well-described safety profile. Apabetalone is currently undergoing clinical evaluation for high-risk cardiovascular disease, COVID-19, and pulmonary arterial hypertension, and is the first therapy of its kind to receive Breakthrough Therapy Designation from the US Food and Drug Administration (FDA).
Job Type: Full-time
Benefits:
Schedule:
Education: